Describe the rotavirus & Pneumococcal of Newer Vaccines.

Rotavirus Vaccine

• Live, oral vaccine against rotavirus — the commonest cause of severe infantile gastroenteritis.
• Given at 6, 10 and 14 weeks; must complete within the recommended age window.
• A small risk of intussusception is noted — avoid a first dose in older infants; counsel on warning signs.

Pneumococcal Conjugate Vaccine (PCV)

• A conjugate vaccine against Streptococcus pneumoniae — prevents pneumonia, meningitis and sepsis.
• Given as a primary series with a booster around 9 months (UIP schedule).

Significance

Rotavirus and PCV target the two biggest infectious killers of under-fives (diarrhoea and pneumonia), and their inclusion in the UIP is a major child-survival advance.

WHY They Matter

Diarrhoea and pneumonia are the two leading infectious causes of under-five death; rotavirus and pneumococcal vaccines directly target them, making their addition to the UIP a major child-survival intervention.

Rotavirus — Practical Points

• Complete the schedule within the recommended age window; counsel families about intussusception warning signs (blood in stool, severe crying, vomiting).
• Being live and oral, it contributes to reducing severe, dehydrating gastroenteritis.

Key Points Recap

• Rotavirus — live oral, 6/10/14 weeks, small intussusception risk.
• PCV — conjugate, primary + booster; both target the leading under-5 killers.

Programme Note

The phased introduction of rotavirus and pneumococcal conjugate vaccines into the UIP reflects a strategy of directly tackling the two commonest infectious causes of under-five mortality.

Exam Relevance

This is a frequently asked short note — remember the vaccine type/route, its place in the UIP schedule, and its key precautions or programmatic significance.

Both target the two leading causes of under-5 mortality.